Clinicopathological Characteristics Related to Etiologies of Erythema Nodosum: A 10-Year Retrospective Study

References

• Requena L, Yus ES. Erythema nodosum. Dermatol Clin. 2008;26(4):425–438, v. doi:10.1016/j.det.2008.05.014
   Web of Science ®Google Scholar
• Schwartz RA, Nervi SJ. Erythema nodosum: a sign of systemic disease. Am Fam Physician. 2007;75(5):695–700.
   Web of Science ®Google Scholar
• Pérez-Garza DM, Chavez-Alvarez S, Ocampo-Candiani J, Gomez-Flores M. Erythema nodosum: a practical approach and diagnostic algorithm. Am J Clin Dermatol. 2021;22(3):367–378. doi:10.1007/s40257-021-00592-w
   PubMed Web of Science ®Google Scholar
• Chowaniec M, Starba A, Wiland P. Erythema nodosum - review of the literature. Reumatologia. 2016;54(2):79–82. doi:10.5114/reum.2016.60217
   PubMedGoogle Scholar
• Patterson JW, Requena L. Panniculitis. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology, 4th. Elsevier Health Sciences; 2018:1733–1757.
   Google Scholar
• Mert A, Kumbasar H, Ozaras R, et al. Erythema nodosum: an evaluation of 100 cases. Clin Exp Rheumatol. 2007;25(4):563–570.
   Web of Science ®Google Scholar
• Thurber S, Kohler S. Histopathologic spectrum of erythema nodosum. J Cutan Pathol. 2006;33(1):18–26. doi:10.1111/j.0303-6987.2006.00402.x
   Web of Science ®Google Scholar
• Blake T, Manahan M, Rodins K. Erythema nodosum - a review of an uncommon panniculitis. Dermatol Online J. 2014;20(4):22376.
   PubMedGoogle Scholar
• Garcia-Porrua C, Gonzalez-Gay MA, Vazquez-Caruncho M, et al. Erythema nodosum: etiologic and predictive factors in a defined population. Arthritis Rheum. 2000;43(3):584–592. doi:10.1002/1529-0131(200003)43:3<584::Aid-anr15>3.0.Co;2-6
   Web of Science ®Google Scholar
• Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol. 1998;37(9):667–672. doi:10.1046/j.1365-4362.1998.00316.x
   Web of Science ®Google Scholar
• Puavilai S, Sakuntabhai A, Sriprachaya-Anunt S, Rajatanavin N, Charuwichitratana S. Etiology of erythema nodosum. J Med Assoc Thai. 1995;78(2):72–75.
   Google Scholar
• Tantisirin O, Puavilai S. Long-term follow-up of erythema nodosum. J Med Assoc Thai. 2003;86(12):1095–1100.
   Google Scholar
• Erez A, Horowitz J, Sukenik S. Erythema nodosum in the negev area–a survey of 50 patients. Isr J Med Sci. 1987;23(12):1228–1231.
   Google Scholar
• Psychos DN, Voulgari PV, Skopouli FN, Drosos AA, Moutsopoulos HM. Erythema nodosum: the underlying conditions. Clin Rheumatol. 2000;19(3):212–216. doi:10.1007/s100670050159
   Web of Science ®Google Scholar
• Mert A, Ozaras R, Tabak F, Pekmezci S, Demirkesen C, Ozturk R. Erythema nodosum: an experience of 10 years. Scand J Infect Dis. 2004;36(6–7):424–427. doi:10.1080/00365540410027184
   PubMed Web of Science ®Google Scholar
• Bohn S, Büchner S, Itin P. Erythema nodosum: 112 cases. epidemiology, clinical aspects and histopathology. Schweiz Med Wochenschr. 1997;127(27–28):1168–1176.
   Google Scholar
• Requena L, Sánchez yus E. Erythema nodosum. Semin Cutan Med Surg. 2007;26(2):114–125. doi:10.1016/j.sder.2007.02.009
   Web of Science ®Google Scholar
• Jones JV, Cumming RH, Asplin CM, Laszlo G, White RJ. Evidence for circulating immune complexes in erythema nodosum and early sarcoidosis. Ann N Y Acad Sci. 1976;278(1 Seventh Inter):212–219. doi:10.1111/j.1749-6632.1976.tb47032.x
   Web of Science ®Google Scholar
• Akdiş AC, Kiliçturgay K, Helvaci S, Mistik R, Oral B. Immunological evaluation of erythema nodosum in tularaemia. Br J Dermatol. 1993;129(3):275–279. doi:10.1111/j.1365-2133.1993.tb11846.x
   PubMed Web of Science ®Google Scholar
• Nunnery E, Persellin RH, Pope RM. Lack of circulating immune complexes in uncomplicated erythema nodosum. J Rheumatol. 1983;10(6):991–994.
   Web of Science ®Google Scholar
• Varas P, Antúnez-Lay A, Bernucci JM, Cossio L, González S, Eymin G. Erythema nodosum: analysis of 91 hospitalized patients. Rev Med Chil. 2016;144(2):162–168. doi:10.4067/s0034-98872016000200003
   Web of Science ®Google Scholar
• Sota Busselo I, Oñate Vergara E, Pérez-Yarza EG, López Palma F, Ruiz Benito A, Albisu Andrade Y. Erythema nodosum: etiological changes in the last two decades. Pediatrics. 2004;61(5):403–407. doi:10.1016/s1695-4033(04)78414-3
   Google Scholar
• Babamahmoudi F, Amuzgar A, Mousavi T, Davoodi L. Erythema nodosum: what should we consider about it? Caspian J Intern Med. 2016;7(4):304–305.
   Google Scholar
• Porges T, Shafat T, Sagy I, et al. Clinical, epidemiological, and etiological changes in erythema nodosum. Isr Med Assoc J. 2018;20(12):770–772.
   Web of Science ®Google Scholar
• Dogan S, Karaduman A, Evans SE. Clinical and laboratory characteristics of patients with erythema nodosum. Skinmed. 2016;14(2):99–103.
   Google Scholar
• Requena L, Yus ES. Panniculitis. Part I. Mostly septal panniculitis. J Am Acad Dermatol. 2001;45(2):163–183;quiz 184–166. doi:10.1067/mjd.2001.114736
   Web of Science ®Google Scholar
• Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American thoracic society/infectious diseases society of America/centers for disease control and prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017;64(2):e1–e33. doi:10.1093/cid/ciw694
   PubMed Web of Science ®Google Scholar
• Raviglione MC. Tuberculosis. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 20th ed. New York, NY: McGraw-Hill Education; 2018:1236–1259.
   Google Scholar
• Holland SM. Nontuberculous mycobacterial infections. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 20th ed. McGraw-Hill Education; 2018:1266–1270.
   Google Scholar
• Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. doi:10.1164/rccm.200604-571ST
   PubMed Web of Science ®Google Scholar
• Ramphal R. Infections due to pseudomonas, burkholderia, and stenotrophomonas species. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 20th ed. New York, NY: McGraw-Hill Education; 2018:1167–1173.
   Google Scholar
• Kotton CN, Hirsch MS. Cytomegalovirus and human herpesvirus types 6, 7, and 8. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 20th ed. New York, NY: McGraw-Hill Education; 2018:1361–1366.
   Google Scholar
• Fauci AS, Folkers GK, Lane HC. Human immunodeficiency virus disease: AIDS and related disorders. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 20th ed. New York, NY: McGraw-Hill Education; 2018:1393–1463.
   Google Scholar
• Rubin SA. Mumps. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 20th ed. New York, NY: McGraw-Hill Education; 2018:1481–1484.
   Google Scholar
• Edwards JEJ. Candidiasis. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 20th ed. New York, NY: McGraw-Hill Education; 2018:1529–1532.
   Google Scholar
• International Study Group for Behcet’s Disease. Criteria for diagnosis of behcet’s disease. Lancet. 1990;335(8697):1078–1080.
   PubMed Web of Science ®Google Scholar
• Davatchi F, Assaad-Khalil S, Calamia KT. International Team for the Revision of the International Criteria for Behcet’s Disease (ITR-ICBD). The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–347. doi:10.1111/jdv.12107
   PubMed Web of Science ®Google Scholar
• Taylor J, Xiao W, Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017;130(4):410–423. doi:10.1182/blood-2017-02-734541
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer; 2017.
   Google Scholar
• Papagrigoraki A, Gisondi P, Rosina P, Cannone M, Girolomoni G. Erythema nodosum: etiological factors and relapses in a retrospective cohort study. Eur J Dermatol. 2010;20(6):773–777. doi:10.1684/ejd.2010.1116
   Web of Science ®Google Scholar
• Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the infectious diseases society of America. Clin Infect Dis. 2012;55(10):e86–e102. doi:10.1093/cid/cis629
   PubMed Web of Science ®Google Scholar
• Jain R, Yadav D, Puranik N, Guleria R, Jin JO. Sarcoidosis: causes, diagnosis, clinical features, and treatments. J Clin Med. 2020;9(4):1081. doi:10.3390/jcm9041081
   PubMed Web of Science ®Google Scholar
• Khan MK, Islam MN, Ferdous J, Alam MM. An overview on epidemiology of tuberculosis. Mymensingh Med J. 2019;28(1):259–266.
   Google Scholar
• Bjorn-Mortensen K, Ladefoged K, Simonsen J, et al. Erythema nodosum and the risk of tuberculosis in a high incidence setting. Int J Circumpolar Health. 2016;75(1):32666. doi:10.3402/ijch.v75.32666
   PubMed Web of Science ®Google Scholar
• Acosta KA, Haver MC, Kelly B. Etiology and therapeutic management of erythema nodosum during pregnancy: an update. Am J Clin Dermatol. 2013;14(3):215–222. doi:10.1007/s40257-013-0024-x
   Web of Science ®Google Scholar
• Ben-Betzalel G, Baruch EN, Boursi B, et al. Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanoma. Eur J Cancer. 2018;101:229–235. doi:10.1016/j.ejca.2018.06.030
   PubMed Web of Science ®Google Scholar
• Degen A, Volker B, Kapp A, Gutzmer R. Erythema nodosum in a patient undergoing vemurafenib therapy for metastatic melanoma. Eur J Dermatol. 2013;23(1):118. doi:10.1684/ejd.2012.1915
   Web of Science ®Google Scholar
• Sinha R, Edmonds K, Newton-Bishop J, Gore M, Larkin J, Fearfield L. Erythema nodosum-like panniculitis in patients with melanoma treated with vemurafenib. J Clin Oncol. 2013;31(19):e320–e321. doi:10.1200/jco.2012.45.8307
   Web of Science ®Google Scholar
• Mossner R, Zimmer L, Berking C, et al. Erythema nodosum-like lesions during BRAF inhibitor therapy: report on 16 new cases and review of the literature. J Eur Acad Dermatol Venereol. 2015;29(9):1797–1806. doi:10.1111/jdv.13039
   Web of Science ®Google Scholar
• Nomiyama J, Shinohara K, Inoue H. Erythema nodosum caused by the administration of granulocyte colony-stimulating factor in a patient with refractory anemia. Am J Hematol. 1994;47(4):333. doi:10.1002/ajh.2830470420
   Web of Science ®Google Scholar
• George S, George B, Gorak E. Erythema nodosum secondary to granulocyte colony-stimulating factor in a patient with hodgkin lymphoma during CD34+ cell mobilization for autologous peripheral blood stem cell transplantation: a dose-mediated effect. Biol Blood Marrow Transplant. 2005;11(10):816–817. doi:10.1016/j.bbmt.2005.07.003
   Web of Science ®Google Scholar
• Wilk M, Zelger BG, Hayani K, Zelger B. Erythema nodosum, early stage—a subcutaneous variant of leukocytoclastic vasculitis? Clinicopathological correlation in a series of 13 patients. Am J Dermatopathol. 9000. Publish Ahead of Print. doi:10.1097/dad.0000000000001469
   Google Scholar
• Alvarez Lario B, Piney E, Rodríguez-Valverde V, Peña Sagredo JL, Peiró Callizo E. Eritema nudoso: estudio de 103 casos [Erythema nodosum: study of 103 cases]. Med Clin (Barc). 1987;88(1):5–8. Spanish.
   Web of Science ®Google Scholar
• Jones M, de Keyser P. Rash on the arms and legs. BMJ. 2015;351:h4131. doi:10.1136/bmj.h4131
   Web of Science ®Google Scholar
• Adame J, Cohen PR. Eosinophilic panniculitis: diagnostic considerations and evaluation. J Am Acad Dermatol. 1996;34(2 Pt 1):229–234. doi:10.1016/s0190-9622(96)80117-4
   Web of Science ®Google Scholar
• Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010;125(2 Suppl 2):S3–S23. doi:10.1016/j.jaci.2009.12.980
   PubMed Web of Science ®Google Scholar
• de Martino M, Lodi L, Galli L, Chiappini E. Immune response to mycobacterium tuberculosis: a narrative review. Front Pediatr. 2019;7:350. doi:10.3389/fped.2019.00350
   PubMed Web of Science ®Google Scholar
• Davido B, Makhloufi S, Matt M, et al. Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy. Int J Infect Dis. 2017;61:62–66. doi:10.1016/j.ijid.2017.06.005
   PubMed Web of Science ®Google Scholar
• Ramirez GA, Yacoub M-R, Ripa M, et al. Eosinophils from physiology to disease: a comprehensive review. Biomed Res Int. 2018;2018:28. doi:10.1155/2018/9095275
   Web of Science ®Google Scholar